Tecan Group Acquires IBL International

Agilent Technologies Acquires Biocare Medical

March 9, 2026

Medical Devices

Agilent Technologies entered into a definitive agreement to acquire Biocare Medical, a global provider of clinical and research pathology solutions, for $950 million in an all-cash transaction. The acquisition expands Agilent’s pathology portfolio—particularly in immunohistochemistry (IHC)—and is expected to be accretive to Agilent’s top-line growth rate, margin profile, and non-instrument revenue mix in Year 1.

Cube Biotech Acquires IBA Lifesciences GmbH

January 13, 2025

Biotechnology

Cube Biotech, a portfolio company of ARCHIMED, has acquired IBA Lifesciences GmbH, a German life‑science tools company known for its Strep‑Tag affinity technology. The deal expands Cube's protein purification product portfolio and strengthens its position in affinity‑tag purification technologies to better serve academic and industry researchers worldwide.

BBI Solutions Acquires IBEX Technologies Inc.

April 8, 2024

Biotechnology

BBI Solutions OEM Limited has acquired IBEX Technologies Inc., a Montreal-based developer and manufacturer of high-precision enzymes and diagnostic solutions, with the transaction closing on April 8, 2024. The acquisition expands BBI's recombinant protein and enzyme capabilities to better serve in-vitro diagnostics (IVD) manufacturers and brings IBEX's staff and contract-manufacturing capabilities into BBI's global operations.

Calibre Scientific Acquires Labtech International Ltd

January 17, 2024

Medical Devices

Calibre Scientific has acquired Labtech International Ltd, a UK-based supplier and service provider of life science instruments, microscopy equipment, consumables and technical services. The acquisition expands Calibre Scientific's analytical instrument and service capabilities across the British Isles, strengthening its product offering and local service footprint for customers in biotechnology, diagnostics, education, environmental and pharmaceutical markets.

IBI Group Acquires Assets of Telenium Inc.

December 10, 2021

Cloud & SaaS

IBI Group Inc. completed the purchase of the assets and intellectual property of Manitoba-based Telenium Inc., including its 511 advanced traveller information solution and road condition reporting system. The acquisition bolsters IBI's Travel-IQ SaaS offering, expands its 511 service footprint across Canadian provinces, and adds recurring revenue and Telenium's software development team to IBI.

BioCheck, Inc. Acquires DRG International, Inc.

August 18, 2021

Medical Devices

BioCheck, Inc. has acquired DRG International, Inc., a manufacturer of clinical diagnostic ELISAs and the DRG:HYBRiD-XL automated analyzer. The deal combines BioCheck's chemiluminescent assay development and automation platform with DRG's R&D, manufacturing and global distribution network to accelerate development and global scale-up of advanced clinical and research diagnostic tests.